Table 7.6a

Immunosuppression Use for Induction, 1993 to 2002

Recipients with Pancreas After Kidney (PAK) Transplants

	Year of Transplant
	1993	1994	1995	1996	1997	1998	1999	2000	2001	2002
Transplants	61	55	67	113	130	157	222	303	307	377
Tx With Immunosuppression Info	61	55	66	107	129	153	217	296	294	363
No Induction Drugs Recorded	100.0%	76.4%	51.5%	29.0%	26.4%	37.3%	32.7%	32.8%	23.5%	27.5%
Drugs	0.0%	0.0%	0.0%	0.0%	-	-	-	-	-	-
ALG
ATG	-	1.8%	6.1%	44.9%	45.7%	18.3%	7.8%	1.7%	0.3%	2.5%
NRATG/NRATS	-	-	-	0.9%	2.3%	1.3%	0.5%	-	-	-
OKT3	0.0%	21.8%	42.4%	29.0%	24.8%	15.0%	9.2%	3.0%	0.7%	1.4%
Thymoglobulin	-	-	-	-	-	0.7%	30.4%	37.5%	51.4%	51.2%
Zenapax	-	-	-	-	-	26.1%	37.3%	32.8%	34.4%	25.9%
Simulect	0.0%	0.0%	0.0%	0.0%	0.8%	9.8%	10.6%	17.2%	13.6%	8.3%

Source: OPTN/SRTR Data as of August 1, 2003.

(-) = Drug not used anytime during the year.

Induction drugs include any reported antilymphocyte antibodies and antibodies directed against lymphocyte receptors.